Geisinger Clinical Oncology Program
盖辛格临床肿瘤学项目
基本信息
- 批准号:7268969
- 负责人:
- 金额:$ 45.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-07-01 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcademyAccountabilityAccountingAcuteAddressAdherenceAdjuvant StudyAdministratorAdoptedAdultAdult Acute Lymphocytic LeukemiaAdult Acute Myeloblastic LeukemiaAffectAgeAgreementAll SitesAmbulatory Surgical ProceduresAmendmentAntineoplastic ProtocolsAppearanceAppointmentAppointments and SchedulesArchivesAreaArtsAsiansAuthorization documentationAverage Household IncomeAwardAwarenessBackBasal CellBasal cell carcinomaBedsBiopsyBladderBlindedBloodBone Marrow TransplantationBostonBoxingBrainBreastBusinessesCalendarCalibrationCancer CenterCancer ControlCancer PatientCancer Prevention TrialCarcinoid TumorCardiovascular systemCaringCatchment AreaCategoriesCellsCentral Nervous System NeoplasmsCertificationCervix UteriChairpersonChemopreventionChemotherapy-Oncologic ProcedureChestChildChildhoodChildhood Acute Lymphocytic LeukemiaChildhood Acute Myeloid LeukemiaChildhood LymphomaChildhood Solid NeoplasmChildren&aposs Oncology GroupClassClinicClinic VisitsClinicalClinical OncologyClinical PharmacistsClinical ProtocolsClinical ResearchClinical Research AssociateClinical TrialsClinical Trials Cooperative GroupClinical Trials[{..}] Cancer TreatmentClinics and HospitalsClosureCodeCollaborationsCollectionColonColonoscopyCommitCommunicationCommunity Clinical Oncology ProgramCommunity HospitalsCommunity PracticeComputerized Medical RecordComputerized Medical Records SystemsComputersConditionConfidentialityConsentConsent FormsConsultContractsControl GroupsControlled StudyCounselingCountCountryCountyCredentialingDNADNA analysisDailyDana-Farber Cancer InstituteDataData CollectionData QualityData SourcesDatabasesDiagnosisDiagnosticDietary InterventionDisciplineDiscipline of NursingDiseaseDistrict of ColumbiaDoctor of MedicineDoctor of PhilosophyDoseDrug PrescriptionsEastern Cooperative Oncology GroupEducational ActivitiesEducational process of instructingElectronic MailElectronicsEmployeeEndocrineEndometrialEndoscopyEnrollmentEnvironmentEsophagusEvaluationEwings sarcomaFamilyFecal occult bloodFecesFellowshipFemaleFemale Genital NeoplasmsFilmFormulariesFox Chase Cancer CenterFundingFutureGelGenus ColaGeographyGleanGoalsGrantGray unit of radiation doseGroup MeetingsGroup PracticeGrowthGuidelinesGynecologicGynecologic OncologistGynecologic OncologyGynecologic Oncology GroupGynecologyHeadHead and Neck CancerHead and Neck NeoplasmsHealth Maintenance OrganizationsHealth PlanningHealth PromotionHealth systemHealthcare SystemsHematologic NeoplasmsHematologistHematologyHemeHepatobiliaryHispanicsHodgkin DiseaseHollyHome environmentHospitalsHourHousingHuman ResourcesHuntington DiseaseImageIncentivesIndividualIndustryIneligibilityInformation SystemsInformation TechnologyInjectableInpatientsInstitutesInstitutionInsuranceInterdisciplinary StudyInternetInvestigational DrugsKaposi SarcomaKidneyLabelLaboratoriesLawsLeadershipLeftLegalLettersLifeLinkLocalesLocationLungLymphocyteMailsMalignant NeoplasmsMalignant neoplasm of prostateMammary NeoplasmsManualsManuscriptsMarketingMeasuresMedicalMedical EducationMedical OncologistMedical OncologyMedical RecordsMedical centerMedicareMedicineMichiganMinnesotaMinorMinorityMissionModelingModificationMonitorMultiple MyelomaNamesNational Cancer InstituteNational Surgical Adjuvant Breast and Bowel ProjectNatureNephroblastomaNeuroblastomaNewly DiagnosedNewsletterNon-Hodgkin&aposs LymphomaNon-Small-Cell Lung CarcinomaNone or Not ApplicableNorth Central Cancer Treatment GroupNumbersNursesOncologic NursingOncologistOncology GroupOncology NurseOntologyOperative Surgical ProceduresOutcomeOutpatientsOutreach ResearchOvaryP1 Bacteriophage Artificial ChromosomesPalliative CarePancreasPanicPaperParticipantPathologistPathologyPatient AppointmentPatient CarePatient MonitoringPatientsPediatric Oncology GroupPenetrationPennsylvaniaPerformancePerformance StatusPersonsPharmaceutical PreparationsPharmacistsPharmacologic SubstancePharmacy facilityPhiladelphiaPhysician ExecutivesPhysiciansPhysicians&apos OfficesPhysicsPoliciesPopulationPopulation-Based RegistryPositioning AttributePrejudicePreventionPrevention ResearchPrevention interventionPrimary Health CarePrincipal InvestigatorPrintingPrivacyPrivate PracticeProceduresProcessProductivityProgress ReportsProstateProstate Cancer Prevention TrialProtocols documentationProviderPurposeQuality ControlQuestionnairesRadiationRadiation OncologistRadiation OncologyRadiation Therapy Oncology GroupRadiology SpecialtyRandomizedRangeRateRecording of previous eventsRecordsRecruitment ActivityRectumRegistered nurseRegistriesReportingResearchResearch ActivityResearch Ethics CommitteesResearch PersonnelResourcesRestRetrievalRewardsRightsRoentgen RaysRoleRunningRuralRural PopulationSamplingSampling StudiesSatellite HospitalsScheduleScienceSecurityServicesSideSiteSite VisitSkinSlideSmokingSolidSourceSouthwest Oncology GroupSpecialistSpecialty BoardsSpecific qualifier valueSpecimenStable PopulationsStandards of Weights and MeasuresStomachStructureSuggestionSupport of ResearchSurgeonSurgical OncologistSurgical OncologySystemTechniquesTelefacsimileTelephoneTestingTestisTherapeutics CommitteeThoracic OncologyThoracic Surgical ProceduresTimeTobaccoToxic effectTrainingTransfusionTreatment ProtocolsUnited StatesUniversitiesUpdateUrologic CancerUterusVisitWagesWeekWomanWomen&aposs HealthWorkWorkplaceWritingWyomingX-Ray Computed Tomographyabstractinganticancer researchauthoritybasecancer carecancer preventioncancer therapychemotherapychronic leukemiacisplatin/cyclophosphamide/doxorubicin protocolcollegecolorectal cancer screeningcomputerizedconceptcostdata managementdaydemographicsdesigndigital imagingexpectationexperiencefallsfirewallfollow-upforgettingglucose-mannose-glucosehospital bedimprovedinterestleukemiamalemalignant breast neoplasmmedical schoolsmedical specialtiesmelanomamembermenmultidisciplinaryneoplasm registryneoplasm resourceoncologyoptimismosteosarcomaoutreachpediatric acute leukemiapediatric departmentplanetary Atmospherepreventprogramsradiologistrepositoryresearch studyresponserestraintrural areasarcomaskin squamous cell carcinomasmoking cessationstatistical centersuccesssymposiumtertiary caretransmission processtreatment trialtumorurologicvolunteer
项目摘要
DESCRIPTION (provided by applicant): The principal objective of the Geisinger Clinical Oncology Program is to enroll a maximum number of participants onto NCI-approved cancer prevention, cancer control and cancer treatment protocols, bringing research-quality cancer care to a large rural population of Pennsylvania. The Geisinger Health System serves more than 2.3 million Pennsylvanians across 31 primarily rural counties in the central and northeastern parts of the state. This Health System includes a 535 physician primary and multispecialty group practice in 45 sites, anchored by the 437 bed tertiary care Geisinger Medical Center in Danville, the largest rural tertiary center in the U.S. The other major hubs of the System are in State College (90-member multispecialty group) and Wilkes-Barre (160 bed hospital with 100-member multispecialty group). These hubs will each be an important CCOP site as well. Geisinger Health system operates a staff model HMO with nearly 300,000 members that works cooperatively with the CCOP to promote cancer prevention trials. Among Geisinger's advantages are a stable and growing CCOP staff with a history of excellent retention of personnel and with successful performance over the 19 year history of the NCI CCOP program. The system enjoys a large network of primary care practices, with all practices and all physicians (including specialists) linked by a state-of-art electronic medical record (EPIC-Care), and a large cancer patient population (over 2000 new analytic cases/year). The addition of new System C.E.O. Dr. Glenn Steele, a prominent academic surgical oncologist and researcher, has given new emphasis to the institutional commitment to growing cancer research. The System has been reorganized into Service Lines, which has greatly aided the Cancer Service Line, Geisinger Cancer Institute, in recruiting and building in all three major hub sites. Clinical trial performance is enhanced by a new computerized clinical protocol management system (Protonet), a System-wide cancer registry that includes all outpatient as well as all hospital sites, and the computerized medical record with interlocked laboratory, radiology, demographics, appointments and on-line digital images. Recruiting participants onto prevention trials has been helped by direct recruiting by Geisinger's HMO, which is clinical research friendly, seeing such activities as part of its primary health promotion mission. This proposal retains NCCTG as the primary research base, ECOG as a secondary base, COG as our children's base, and GOG (MD Anderson affiliation) as a separate gynecologic base.
描述(由申请人提供):Geisinger临床肿瘤学计划的主要目标是将最大数量的参与者纳入NCI批准的预防癌症预防,癌症控制和癌症治疗方案,从而为宾夕法尼亚州的大型农村人口带来研究质量的癌症护理。盖辛格卫生系统为该州中部和东北部的31个乡村县提供了230万以上宾夕法尼亚州。该卫生系统包括45个地点的535个医师小组练习,由美国最大的乡村三级中心的437床三级护理盖辛格医疗中心锚定,该系统的其他主要枢纽是州立大学(90-MERBECELTY GROUP)(90-MERPECIALTY GROUP)和WILKES-BARRE(WILKES-BARRE)(160 MELTIS)。这些枢纽也将是一个重要的CCOP站点。 Geisinger Health System与HMO建模的员工Model Mode Mo与CCOP合作以促进癌症预防试验的近300,000名成员。在Geisinger的优势中,有一位稳定且不断增长的CCOP员工,其历史悠久,在NCI CCOP计划的19年历史中,具有出色的人员保留史。该系统享有大型的初级保健实践网络,所有实践和所有医生(包括专家)(包括最先进的电子病历(Epic-Care)(Epic-Care)和大量癌症患者人群(超过2000个新的分析案例/年)。添加了新系统C.E.O.著名的学术外科肿瘤学家兼研究人员Glenn Steele博士已将机构对不断发展的癌症研究的承诺提出了新的重视。该系统已被重组为服务线,该系统极大地帮助了盖辛格癌症研究所(Geisinger Cancer Institute)的癌症服务线,并在所有三个主要枢纽站点招募和建造。新的计算机化临床协议管理系统(Protonet)增强了临床试验性能,该系统包括所有门诊以及所有医院现场,以及具有互锁实验室,放射学,人口统计学,任命和跨线数字图像的计算机化病历。 Geisinger's HMO的直接招募帮助临床研究友好的招募参与者已将这些活动视为其主要健康促进任务的一部分。该提案将NCCTG保留为主要研究基础,ECOG作为次要基础,COG作为我们的孩子的基础,而GOG(MD Anderson隶属关系)作为单独的妇科基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Albert Michael Bernath其他文献
Albert Michael Bernath的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Albert Michael Bernath', 18)}}的其他基金
相似国自然基金
问责制度何以影响地方政府绩效——目标责任制情境下的“问责悖论”研究
- 批准号:71103140
- 批准年份:2011
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Improving the Risk Adjustment Method for Quality Care Measures through Application of an Innovative Individual-Level Socioeconomic Measure
通过应用创新的个人层面的社会经济措施,改进优质护理措施的风险调整方法
- 批准号:
10213256 - 财政年份:2021
- 资助金额:
$ 45.89万 - 项目类别:
Improving the Risk Adjustment Method for Quality Care Measures through Application of an Innovative Individual-Level Socioeconomic Measure
通过应用创新的个人层面的社会经济措施,改进优质护理措施的风险调整方法
- 批准号:
10394328 - 财政年份:2021
- 资助金额:
$ 45.89万 - 项目类别: